Baia G - Search Results

1

Comparative mutational landscape analysis of patient-derived tumour xenografts.

Brait M, Izumchenko E, Kagohara LT, Long S, Wysocki PT, Faherty B, Fertig EJ, Khor TO, Bruckheimer E, Baia G, Ciznadija D, Sloma I, Ben-Zvi I, Paz K, Sidransky D. Brait M, et al. Among authors: baia g. Br J Cancer. 2017 Feb 14;116(4):515-523. doi: 10.1038/bjc.2016.450. Epub 2017 Jan 24. Br J Cancer. 2017. PMID: 28118322 Free PMC article.

2

Milk derived colloid as a novel drug delivery carrier for breast cancer.

Hayashi M, Silanikove N, Chang X, Ravi R, Pham V, Baia G, Paz K, Brait M, Koch WM, Sidransky D. Hayashi M, et al. Among authors: baia g. Cancer Biol Ther. 2015;16(8):1184-93. doi: 10.1080/15384047.2015.1056416. Cancer Biol Ther. 2015. PMID: 26046946 Free PMC article.

3

5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.

Borodovsky A, Salmasi V, Turcan S, Fabius AW, Baia GS, Eberhart CG, Weingart JD, Gallia GL, Baylin SB, Chan TA, Riggins GJ. Borodovsky A, et al. Among authors: baia gs. Oncotarget. 2013 Oct;4(10):1737-47. doi: 10.18632/oncotarget.1408. Oncotarget. 2013. PMID: 24077805 Free PMC article.

4

Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.

Baia GS, Caballero OL, Orr BA, Lal A, Ho JS, Cowdrey C, Tihan T, Mawrin C, Riggins GJ. Baia GS, et al. Mol Cancer Res. 2012 Jul;10(7):904-13. doi: 10.1158/1541-7786.MCR-12-0116. Epub 2012 May 22. Mol Cancer Res. 2012. PMID: 22618028 Free PMC article.

5

Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors.

Yamashita AS, Baia GS, Ho JS, Velarde E, Wong J, Gallia GL, Belzberg AJ, Kimura ET, Riggins GJ. Yamashita AS, et al. Among authors: baia gs. J Neurooncol. 2014 May;118(1):83-92. doi: 10.1007/s11060-014-1422-5. Epub 2014 Mar 26. J Neurooncol. 2014. PMID: 24668609 Free PMC article.

6

The Hippo signaling pathway and translational opportunities for brain cancers.

Baia GS, Caballero OL, Riggins GJ. Baia GS, et al. CNS Oncol. 2012 Nov;1(2):113-5. doi: 10.2217/cns.12.18. CNS Oncol. 2012. PMID: 25057858 Free PMC article. No abstract available.

7

Molecular signatures define two main classes of meningiomas.

Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A. Carvalho LH, et al. Mol Cancer. 2007 Oct 15;6:64. doi: 10.1186/1476-4598-6-64. Mol Cancer. 2007. PMID: 17937814 Free PMC article.

8

NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.

Baia GS, Caballero OL, Ho JS, Zhao Q, Cohen T, Binder ZA, Salmasi V, Gallia GL, Quinones-Hinojosa A, Olivi A, Brem H, Burger P, Strausberg RL, Simpson AJ, Eberhart CG, Riggins GJ. Baia GS, et al. Cancer Immunol Res. 2013 Nov;1(5):296-302. doi: 10.1158/2326-6066.CIR-13-0029. Epub 2013 Aug 5. Cancer Immunol Res. 2013. PMID: 24777967

9

Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas.

Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A. Baia GS, et al. Neoplasia. 2008 Jun;10(6):604-12. doi: 10.1593/neo.08356. Neoplasia. 2008. PMID: 18516297 Free PMC article.

10

Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.

Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A. Yoo H, et al. Clin Cancer Res. 2007 Jan 1;13(1):68-75. doi: 10.1158/1078-0432.CCR-06-1377. Clin Cancer Res. 2007. PMID: 17200340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page